文献速递瓣膜外科

既往二尖瓣手术后的经导管主动脉瓣置入经验

Transcatheter aortic valve insertion after previous mitral valve operation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-04-04

该单中心回顾性研究纳入772例经导管主动脉瓣置入患者,其中18例(2%)有既往二尖瓣手术史。结果显示手术全部成功,无手术相关死亡或急性二尖瓣功能障碍,1年生存率90.9%±9.1%,提示不应仅因既往二尖瓣手术而拒绝经导管主动脉瓣置入。

要点

  • 既往二尖瓣手术后经导管主动脉瓣置入手术成功率高,无手术相关死亡。
  • 术后无中度及以上主动脉瓣瓣周漏,二尖瓣功能稳定。
  • 1年生存率90.9%±9.1%,支持该操作安全有效。

核心结论

  • 既往二尖瓣手术后行经导管主动脉瓣置入看似安全有效,不应仅因既往二尖瓣手术而拒绝该操作。

研究设计与样本

  • 单中心回顾性研究,纳入2008年11月至2016年8月连续772例经导管主动脉瓣置入患者,其中18例(2%)有既往二尖瓣手术史(修复4例,置换14例)。

主要发现

  • 患者年龄77岁(四分位距68,84),女性11例(61%),NYHA III/IV级14例(78%),STS预测死亡风险7.0%(5.3,12.0)。
  • 经股动脉入路14例(78%),球囊扩张装置10例(56%),所有患者瓣膜置入成功。
  • 无患者发生急性二尖瓣功能障碍或手术相关死亡。
  • 随访超声显示平均主动脉瓣收缩期压差9 mmHg(8,12),无中度及以上主动脉瓣瓣周漏,二尖瓣功能稳定。
  • Kaplan-Meier估计1年生存率为90.9%±9.1%。

临床怎么用

  • 对于有既往二尖瓣手术史的重度主动脉瓣狭窄患者,经导管主动脉瓣置入可作为治疗选择,不应仅因既往二尖瓣手术而排除。

局限性

  • 单中心回顾性研究,样本量小(仅18例有既往二尖瓣手术史),结果需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There are limited data on transcatheter aortic valve insertion after previous mitral valve operation. To better understand the associated procedural risks, we reviewed our single-center experience. METHODS: We retrospectively reviewed the records of 772 consecutive patients who received transcatheter aortic valve insertion from November 2008 through August 2016. There were 18 (2%) patients who had previous mitral valve operation that included valve repair in 4 patients (22%) and replacement in 14 (78%). RESULTS: Baseline characteristics included age of 77 years (interquartile range 68, 84), female sex in 11 patients (61%), New York Heart Association functional class III/IV in 14 (78%), and Society of Thoracic Surgeons predicted risk of mortality of 7.0% (5.3, 12.0). Access was transfemoral in 14 patients (78%). Valve insertion was successful in all patients and involved a balloon expandable device in 10 (56%). No patient experienced acute mitral valve dysfunction or procedure-related mortality. Follow-up echocardiography demonstrated mean systolic aortic valve gradient of 9 mm Hg (8, 12), no grade moderate or greater aortic paravalvular regurgitation, and stable mitral valve function. Kaplan-Meier estimated survival was 90.9% ± 9.1% at 1 year. CONCLUSIONS: Transcatheter aortic valve insertion appears to be a safe and effective operation after previous mitral valve operation. Procedure success was achieved with both balloon expandable and self-expanding devices and was independent of arterial access method. Transcatheter valve insertion should not be denied strictly on the basis of a previous mitral valve operation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Greason KL, Sandhu GS, Nkomo VT, et al. Transcatheter aortic valve insertion after previous mitral valve operation. J Thorac Cardiovasc Surg. 2017. PMID: 28483264. doi:10.1016/j.jtcvs.2017.03.118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。